A common uptake system for serotonin and dopamine in human platelets.
Open Access
- 1 August 1978
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 62 (2) , 235-240
- https://doi.org/10.1172/jci109121
Abstract
Kinetic and pharmacologic properties of uptake of serotonin and dopamine by normal human platelets have been investigated to test whether platelets can be employed as a model system for the reuptake of serotonin and dopamine in brain. Uptake of serotonin into platelets closely resembles reuptake of serotonin into serotonergic neurons. In contrast, uptake of dopamine into platelets appears to be mediated inefficiently via the specific serotonin uptake mechanism, based upon several lines of evidence. Serotonin and dopamine compete with each other, Antidepressant drugs, which are competitive inhibitors of uptake of both of these neurotransmitters, act at the same concentration of drug despite large differences in the Km values. Serotonin antagonists inhibit both serotonin and dopamine uptake. Finally, a serotonin-specific uptake inhibitor (fluoxetine) blocks dopamine, as well as serotonin, uptake.This publication has 32 references indexed in Scilit:
- A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamineLife Sciences, 1974
- Studies of Platelet 5-Hydroxytryptamine (Serotonin) in Storage Pool Disease and AlbinismJournal of Clinical Investigation, 1974
- Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatumJournal of Pharmacy and Pharmacology, 1974
- A comparison of the serotonin and ATP content in platelets from subjects with Down's syndromeBiochemical Medicine, 1974
- DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITYJournal of Neurochemistry, 1974
- Blood platelets as a model for monoamine-containing neuronesProgress in Neurobiology, 1973
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neuronsNeuropharmacology, 1971
- Release of 5-hydroxytryptamine from blood plateletsJournal of Pharmacy and Pharmacology, 1965
- 5-HYDROXYTRYPTAMINE DEFICIENCY IN PHENYLKETONURIAThe Lancet, 1957